BMCMI
ANGO icon

Bryn Mawr Capital Management Inc’s AngioDynamics ANGO Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-29,486
Closed -$525K – 454
2015
Q1 		$525K Buy
+29,486
New +$548K 0.07% 235
2014
Q4 		– Sell
-65,833
Closed -$903K – 486
2014
Q3 		$903K Buy
65,833
+15,700
+31% +$224K 0.09% 221
2014
Q2 		$819K Buy
50,133
+13,746
+38% +$199K 0.08% 240
2014
Q1 		$573K Buy
36,387
+5,147
+16% +$83.9K 0.05% 306
2013
Q4 		$536K Buy
31,240
+1,915
+7% +$29.5K 0.03% 323
2013
Q3 		$387K Sell
29,325
-6,185
-17% -$72.9K 0.02% 385
2013
Q2 		$401K Buy
+35,510
New +$378K 0.03% 257

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bryn Mawr Capital Management Inc's ANGO Position: Q2 2015 in Review

Bryn Mawr Capital Management Inc sold out of AngioDynamics (ANGO) in Q2 2015, closing a stake of 29,486 shares — an estimated $525K sold.

Bryn Mawr Capital Management Inc first reported a position in ANGO in Q2 2013 and held it in 7 quarters. The position peaked at $903K in Q3 2014. 116 funds tracked by Wall St. Rank hold ANGO as of Q2 2015.

  • Bryn Mawr Capital Management Inc reported no remaining AngioDynamics position as of Q2 2015 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 29,486 AngioDynamics shares in Q2 2015, an estimated $525K.
  • Bryn Mawr Capital Management Inc first reported a position in AngioDynamics in Q2 2013 and held it in 7 quarters.
  • Bryn Mawr Capital Management Inc's AngioDynamics position peaked at $903K in Q3 2014.
  • 116 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q2 2015, filed 7 Aug 2015.